Literature DB >> 30466839

Contraception for Adolescents with Medically Complex Conditions.

Linda Carmine1.   

Abstract

Both the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) have developed, published, and updated evidence-based guidelines to support medical providers in the provision of contraceptives to patients with specific medical conditions or characteristics. The goal of these guidelines is to provide recommendations on the safe use of contraceptives with the goal of removing unnecessary medical barriers to access and use of contraceptives, thus decreasing the number of unintended pregnancies. Many medical conditions increase a patient's risk of venous thromboembolism; a risk that may also be increased with specific contraceptives. Specific conditions that require more enhanced contraceptive counseling due to their frequency in adolescence and their association either with adverse events during pregnancy or with increased risk for specific contraceptives are detailed by the WHO and CDC and are summarized herein. Adolescents with morbid obesity, migraine headache, cardiac conditions, hypertension, diabetes mellitus, hyperlipidemia, systemic lupus erythematosus, sickle cell anemia, cystic fibrosis, inflammatory bowel disease, or seizure disorders would benefit from greater attention to the urgency of exploring highly effective contraceptive methods. Details of the considerations that should be used in providing contraceptive care to adolescents with each of these medical conditions, as per WHO and CDC guidelines, are provided in this review. The ultimate goal in contraceptive counseling is the balancing of risk and benefit to arrive at the best therapeutic option, maintaining patient preference as a priority, as that will enhance adherence and comfort with the contraceptive method. Each patient must be assessed for pregnancy risk and be allowed full risk reduction and education regarding contraceptive options.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30466839     DOI: 10.1016/j.cppeds.2018.11.004

Source DB:  PubMed          Journal:  Curr Probl Pediatr Adolesc Health Care        ISSN: 1538-3199


  4 in total

Review 1.  Contraception for Adolescents and Young Women with Type 2 Diabetes-Specific Considerations.

Authors:  Paulina M Merino; Ethel Codner
Journal:  Curr Diab Rep       Date:  2022-02-12       Impact factor: 4.810

2.  The Impact of Progestin-only Contraception on Adolescents with Macromastia.

Authors:  Laura C Nuzzi; Tannishtha Pramanick; Gabrielle G Massey; Landis R Walsh; Catherine T McNamara; Joseph M Firriolo; Amy D DiVasta; Brian I Labow
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-02-12

3.  The risk factors of gestational hypertension in patients with polycystic ovary syndrome: a retrospective analysis.

Authors:  Shu Zhou; Yiping Ji; Haimei Wang
Journal:  BMC Pregnancy Childbirth       Date:  2021-04-27       Impact factor: 3.007

4.  Patterns of contraceptive use among young Australian women with chronic disease: findings from a prospective cohort study.

Authors:  Melissa L Harris; Nicholas Egan; Peta M Forder; Deborah Bateson; Aaron L Sverdlov; Vanessa E Murphy; Deborah Loxton
Journal:  Reprod Health       Date:  2022-05-07       Impact factor: 3.355

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.